Stockholm (HedgeNordic) – A month after expanding its portfolio management team with a fourth portfolio manager, Rhenman & Partners is now strengthening its client-facing team. The healthcare-focused asset manager has appointed Mattias Hagen as Investor Relations Director, joining Erica von Bahr and Tom Josephson in their efforts to engage with investors.

Hagen joins from Carnegie Fonder, where he worked in institutional sales since early 2022. His previous experience includes roles as sales director for the Nordic region at Invesco and executive director at Goldman Sachs. His early career saw him working as a fund analyst at Skandia for more than seven years before moving to SEB Wealth Management, where he spent a decade in various roles, including as Head of Manager Research.

“It is very exciting and inspiring to join Rhenman & Partners. I see them as one of the Nordic region’s strongest niche asset managers,” Mattias Hagen comments on joining Rhenman & Partners. “I look forward to being a part of the continued development of the firm.” His recruitment is one of several key hires at Rhenman & Partners this year. Earlier in 2024, Tom Josephson joined the firm’s investor relations team, and in September, Camilla Oxhamre Cruse joined the investment team as a biopharma-focused portfolio manager. Hagen will assume his new role in October, based out of the firm’s Stockholm office.

“It is very exciting and inspiring to join Rhenman & Partners. I see them as one of the Nordic region’s strongest niche asset managers.”

Mattias Hagen

“We are very pleased that Mattias is joining Rhenman & Partners. His broad skill set and experience make him a strong addition to our organization,” says Teresa Isele, CEO of Rhenman & Partners. Mattias will be an important part of our contacts with investors, both in Sweden and internationally.”

“We are very pleased that Mattias is joining Rhenman & Partners. His broad skill set and experience make him a strong addition to our organization.”

Teresa Isele, CEO of Rhenman & Partners.

Rhenman & Partners manages the Rhenman Healthcare Equity L/S, a long-biased long/short equity fund focused on the healthcare sector. The fund is one of the largest long/short equity funds in the Nordic hedge fund industry, with €845 million in assets under management as of the end of September. Led by founder and CIO Henrik Rhenman since its inception in mid-2009, Rhenman Healthcare Equity L/S has achieved an annualized return of 16.8 percent for the share class reflected in the Nordic Hedge Index. The fund has gained 23.2 percent in the first eight months of 2024, placing it among the top-performing Nordic hedge funds this year.